Three-country retrospective persistence and switching analysis.
Budget vs actual spend
$58k
of $70k planned (83%)
Spend is in line with or behind elapsed time. Elapsed: 76%.
Late-by counts days between due date and completion, or due date and today for open milestones.
| Milestone | Due | Completed | Status | Timing | Late by | Evidence |
|---|---|---|---|---|---|---|
| Analysis complete | 31 Mar 2026 | 27 Mar 2026 | Completed | Completed on time | — | — |
| Manuscript submitted | 15 Jul 2026 | 11 Jul 2026 | Completed | Completed on time | — | Submitted to Cephalalgia |
| Revision returned | 15 Oct 2026 | — | In progress | Upcoming | — | — |
Insights routed to this initiative.
Drug interactions: practice variation observed reported by primary care physician (ES).
Adherence and persistence · 28 Jul 2026
Chronic migraine data: practice variation observed reported by primary care physician (CA).
Medical-information need · 24 Jun 2026
Elderly / ECOG 2 patients: practice variation observed reported by thoracic medical oncologist (FR).
Competitor activity · 09 May 2026
Duration of response: recurring question reported by thoracic medical oncologist (US).
Product understanding · 08 May 2026
Infusion-reaction management: practice variation observed reported by headache specialist (ES).
Product understanding · 02 Mar 2026
Steroid-sparing strategies: interest in collaboration reported by renal pathologist (FR).
Evidence gap · 01 Feb 2026
Phase IIb efficacy: request for data reported by allergist (DE).
Product understanding · 19 Jan 2026
Actions whose result record is this initiative.
No actions reference this initiative as their result.
Nothing is linked.
Same objective (SO-LMV-01)
Same objective (SO-LMV-01)
Same objective (SO-LMV-01)
No tasks are linked to this initiative
No audit events for this record
Audit events are written when the record is created, changed, approved, signed or exported.
Data lineage